3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

To learn if it is effective to use advanced radiation treatment techniques (stereotactic radiation or "SBRT") to safely deliver a strong dose of radiation to your tumor in a shorter period of time than would typically be feasible with traditional methods.

Eligibility criteria

Qualifiers

Age 18 or older

Willing to provide informed consent

Histologically confirmed squamous cell carcinoma

Primary tumor site in the head and neck (includes oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, salivary gland, and cutaneous subsites as well as tumors of unknown primary site)

Disqualifiers

Contraindications to radiotherapy

Pregnant or lactating women

History and physical examination including laryngopharyngoscopy by a radiation oncologist and/or head and neck surgeon within 8 weeks prior to randomization.

Documentation of smoking history

Trial design

Treatments tested in this trial

  • Stereotactic body radiotherapy
  • Traditional Palliation

Treatment groups

108 Participants
are divided into 2 treatment groups

Sponsors and collaborators